{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:40:12Z","timestamp":1793742012576,"version":"4.6.1"},"reference-count":127,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immunotherapy for hematological malignancies is a rapidly advancing field that has gained momentum in recent years, primarily encompassing chimeric antigen receptor T-cell (CAR-T) therapies, immune checkpoint inhibitors, and other modalities. However, its clinical efficacy remains limited, and drug resistance poses a significant challenge. Therefore, novel immunotherapeutic targets and agents need to be identified. Recently, N6-methyladenosine (m6A), the most prevalent RNA epitope modification, has emerged as a pivotal factor in various malignancies. Reportedly, m6A mutations influence the immunological microenvironment of hematological malignancies, leading to immune evasion and compromising the anti-tumor immune response in hematological malignancies. In this review, we comprehensively summarize the roles of the currently identified m6A modifications in various hematological malignancies, with a particular focus on their impact on the immune microenvironment. Additionally, we provide an overview of the research progress made in developing m6A-targeted drugs for hematological tumor therapy, to offer novel clinical insights.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1374390","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T04:55:35Z","timestamp":1716872135000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["A new perspective on hematological malignancies: m6A modification in immune microenvironment"],"prefix":"10.3389","volume":"15","author":[{"given":"Shiyu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihui","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176091","article-title":"Drug resistance in hematological malignancies","volume":"21","author":"Auberger","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01852-w","article-title":"Survival in hematological malignancies in the nordic countries through a half century with correlation to treatment","volume":"37","author":"Hemminki","year":"2023","journal-title":"Leukemia"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24129816","article-title":"Molecular aspects of hematological malignancies and benign hematological disorders","volume":"24","author":"Gaman","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3322\/caac.21765","article-title":"Cancer epigenetics in clinical practice","volume":"73","author":"Davalos","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tig.2022.10.004","article-title":"Genetic and epigenetic defects of the RNA modification machinery in cancer","volume":"39","author":"Orsolic","year":"2023","journal-title":"Trends Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of methylated nucleosides in messenger RNA from novikoff hepatoma cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc Natl Acad Sci USA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1128\/JVI.20.1.45-53.1976","article-title":"Influenza viral mRNA contains internal N6-methyladenosine and 5'-terminal 7-methylguanosine in cap structures","volume":"20","author":"Krug","year":"1976","journal-title":"J Virol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1105\/tpc.108.058883","article-title":"MTA is an arabidopsis messenger RNA adenosine methylase and interacts with a homolog of a sex-specific splicing factor","volume":"20","author":"Zhong","year":"2008","journal-title":"Plant Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2014.3","article-title":"Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase","volume":"24","author":"Ping","year":"2014","journal-title":"Cell Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cell.2013.10.026","article-title":"RNA-methylation-dependent RNA processing controls the speed of the circadian clock","volume":"155","author":"Fustin","year":"2013","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nature15377","article-title":"Dynamic m(6)A mRNA methylation directs translational control of heat shock response","volume":"526","author":"Zhou","year":"2015","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2902","article-title":"N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells","volume":"16","author":"Wang","year":"2014","journal-title":"Nat Cell Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.99","article-title":"Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis","volume":"27","author":"Hsu","year":"2017","journal-title":"Cell Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.789914","article-title":"m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in acute myeloid leukemia","volume":"12","author":"Du","year":"2021","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-022-09718-0","article-title":"Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA\u2002MIR155HG to upregulate PD-L1 expression","volume":"38","author":"Peng","year":"2022","journal-title":"Cell Biol Toxicol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","article-title":"m(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade","volume":"10","author":"Yang","year":"2019","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)32497-3","article-title":"Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. internal mRNA methylation requires a multisubunit complex","volume":"269","author":"Bokar","year":"1994","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41589-018-0184-3","article-title":"N(6-)Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation","volume":"15","author":"Ma","year":"2019","journal-title":"Nat Chem Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.molcel.2018.08.004","article-title":"Methylation of structured RNA by the m(6)A writer METTL16 is essential for mouse embryonic development","volume":"71","author":"Mendel","year":"2018","journal-title":"Mol Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-018-0019-0","article-title":"VIRMA mediates preferential m(6)A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation","volume":"4","author":"Yue","year":"2018","journal-title":"Cell Discovery"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat Chem Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature18298","article-title":"Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex","volume":"534","author":"Wang","year":"2016","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2017.1282025","article-title":"Human m(6)A writers: Two subunits, 2 roles","volume":"14","author":"Wang","year":"2017","journal-title":"RNA Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-021-01129-8","article-title":"N6-methyladenosine methyltransferases: functions, regulation, and clinical potential","volume":"14","author":"Huang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature19342","article-title":"m(6)A RNA methylation promotes XIST-mediated transcriptional repression","volume":"537","author":"Patil","year":"2016","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1038\/s41598-023-28739-1","article-title":"Identification of osteosarcoma m6A-related prognostic biomarkers using artificial intelligence: RBM15","volume":"13","author":"Jiang","year":"2023","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.842833","article-title":"N6-methyladenosine methylation regulator RBM15 is a potential prognostic biomarker and promotes cell proliferation in pancreatic adenocarcinoma","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.molcel.2018.02.015","article-title":"Zc3h13 regulates nuclear RNA m(6)A methylation and mouse embryonic stem cell self-renewal","volume":"69","author":"Wen","year":"2018","journal-title":"Mol Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/science.1151710","article-title":"The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase","volume":"318","author":"Gerken","year":"2007","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/ng.713","article-title":"Overexpression of fto leads to increased food intake and results in obesity","volume":"42","author":"Church","year":"2010","journal-title":"Nat Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1000599","DOI":"10.1371\/journal.pgen.1000599","article-title":"A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene","volume":"5","author":"Church","year":"2009","journal-title":"PloS Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-0468","article-title":"M(6)A demethylase ALKBH5 regulates PD-L1 expression and tumor immunoenvironment in intrahepatic cholangiocarcinoma","volume":"81","author":"Qiu","year":"2021","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007412","article-title":"Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development","volume":"14","author":"Kasowitz","year":"2018","journal-title":"PloS Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011707","article-title":"A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication","volume":"138","author":"Sheng","year":"2021","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7554\/elife.31311","article-title":"YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs","volume":"6","author":"Roundtree","year":"2017","journal-title":"Elife"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03313-9","article-title":"The RNA m(6)A reader YTHDC1 silences retrotransposons and guards ES cell identity","volume":"591","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-4249","article-title":"The RNA m6A reader YTHDF1 is required for acute myeloid leukemia progression","volume":"83","author":"Hong","year":"2023","journal-title":"Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","article-title":"A unified model for the function of YTHDF proteins in regulating m(6)A-modified mRNA","volume":"181","author":"Zaccara","year":"2020","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.011","article-title":"HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events","volume":"162","author":"Alarc\u00f3n","year":"2015","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"DiNardo","year":"2023","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4416","article-title":"The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 inhibits hematopoietic Stem\/Progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.7150\/jca.60381","article-title":"The m(6)A RNA methyltransferase METTL3\/METTL14 promotes leukemogenesis through the mdm2\/p53 pathway in acute myeloid leukemia","volume":"13","author":"Sang","year":"2022","journal-title":"J Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.16","article-title":"WTAP is a novel oncogenic protein in acute myeloid leukemia","volume":"28","author":"Bansal","year":"2014","journal-title":"Leukemia"},{"key":"B53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.817584","article-title":"Mutant NPM1-regulated FTO-mediated m(6)A demethylation promotes leukemic cell survival via PDGFRB\/ERK signaling axis","volume":"12","author":"Xiao","year":"2022","journal-title":"Front Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113163","article-title":"ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m(6)A modification-mediated RNA stability control","volume":"42","author":"Gao","year":"2023","journal-title":"Cell Rep"},{"key":"B56","doi-asserted-by":"publisher","first-page":"20230766","DOI":"10.1515\/med-2023-0766","article-title":"Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells","volume":"18","author":"Yang","year":"2023","journal-title":"Open Med (Wars)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","article-title":"Targeting the RNA m(6)A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia","volume":"25","author":"Paris","year":"2019","journal-title":"Cell Stem Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-228130","article-title":"PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice","volume":"115","author":"Peng","year":"2010","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16478","article-title":"Dysregulation of LINC00470 and METTL3 promotes chemoresistance and suppresses autophagy of chronic myelocytic leukaemia cells","volume":"25","author":"Lai","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41419-021-04169-7","article-title":"New insight into the catalytic -dependent and -independent roles of METTL3 in sustaining aberrant translation in chronic myeloid leukemia","volume":"12","author":"Ianniello","year":"2021","journal-title":"Cell Death Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-022-00762-w","article-title":"YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m(6)A-mediated YWHAZ stability","volume":"46","author":"Chai","year":"2023","journal-title":"Cell Oncol (Dordr)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cvsm.2022.07.009","article-title":"Diagnosing multiple myeloma and related disorders","volume":"53","author":"Moore","year":"2023","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"B63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-021-01066-6","article-title":"HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA","volume":"14","author":"Jiang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12967-023-03904-2","article-title":"HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma","volume":"20","author":"Jia","year":"2022","journal-title":"J Transl Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02675-w","article-title":"N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1\/p21(cip1\/waf1)\/CDK2-cyclin E1 axis-mediated cell cycle transition","volume":"42","author":"Liu","year":"2023","journal-title":"Oncogene"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-022-02191-3","article-title":"YTHDF2 promotes multiple myeloma cell proliferation via STAT5A\/MAP2K2\/p-ERK axis","volume":"41","author":"Hua","year":"2022","journal-title":"Oncogene"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04906-w","article-title":"N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1","author":"Bao","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"B68","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12964-018-0258-6","article-title":"Wilms' tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90","volume":"16","author":"Kuai","year":"2018","journal-title":"Cell Commun Signal"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003764","article-title":"piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL","volume":"137","author":"Han","year":"2021","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12022","article-title":"Expression and roles of Wilms' tumor 1-associating protein in glioblastoma","volume":"103","author":"Jin","year":"2012","journal-title":"Cancer Sci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"779","DOI":"10.21037\/atm-22-3027","article-title":"The m(6)A methyltransferase WTAP plays a key role in the development of diffuse large B-cell lymphoma via regulating the m(6)A modification of catenin beta 1","volume":"10","author":"Guo","year":"2022","journal-title":"Ann Transl Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41420-022-00819-7","article-title":"ALKBH5-mediated N(6)-methyladenosine modification of TRERNA1 promotes DLBCL proliferation via p21 downregulation","volume":"8","author":"Song","year":"2022","journal-title":"Cell Death Discovery"},{"key":"B73","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s11658-023-00445-w","article-title":"KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating hippo-YAP pathway","volume":"28","author":"Chen","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"B74","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2631","article-title":"A milestone review on how macrophages affect tumor growth","volume":"76","author":"Caux","year":"2016","journal-title":"Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"C762","DOI":"10.1152\/ajpcell.00212.2019","article-title":"The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA","volume":"317","author":"Liu","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41467-021-21514-8","article-title":"RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming","volume":"12","author":"Yin","year":"2021","journal-title":"Nat Commun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109553","article-title":"N6-methyladenosine demethylase FTO promotes M1 and M2 macrophage activation","volume":"69","author":"Gu","year":"2020","journal-title":"Cell Signal"},{"key":"B79","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","article-title":"NK cell-based cancer immunotherapy: from basic biology to clinical development","volume":"14","author":"Liu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2429","article-title":"Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells","volume":"66","author":"Roda","year":"2006","journal-title":"Cancer Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e20210279","DOI":"10.1084\/jem.20210279","article-title":"The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity","volume":"218","author":"Ma","year":"2021","journal-title":"J Exp Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1038\/s41467-021-25803-0","article-title":"METTL3-mediated m(6)A RNA methylation promotes the anti-tumour immunity of natural killer cells","volume":"12","author":"Song","year":"2021","journal-title":"Nat Commun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between a CD4+ t-helper and a t-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s41467-019-09903-6","article-title":"Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation","volume":"10","author":"Wang","year":"2019","journal-title":"Nat Commun"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/nri798","article-title":"T-cell development and the CD4-CD8 lineage decision","volume":"2","author":"Germain","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/nature23450","article-title":"m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways","volume":"548","author":"Li","year":"2017","journal-title":"Nature"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.06.005","article-title":"Metabolic regulation of tregs in cancer: Opportunities for immunotherapy","volume":"3","author":"Wang","year":"2017","journal-title":"Trends Cancer"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2018.7","article-title":"m(6)A mRNA methylation sustains treg suppressive functions","volume":"28","author":"Tong","year":"2018","journal-title":"Cell Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2020.07.001","article-title":"A new model of spontaneous colitis in mice induced by deletion of an RNA m(6)A methyltransferase component METTL14 in T cells","volume":"10","author":"Lu","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1918986117","article-title":"ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment","volume":"117","author":"Li","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J"},{"key":"B94","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J Exp Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx316","article-title":"Beyond first-line non-anthracycline-based chemotherapy for extranodal NK\/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease","volume":"28","author":"Lim","year":"2017","journal-title":"Ann Oncol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.99","article-title":"Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas","volume":"30","author":"Messina","year":"2011","journal-title":"Oncogene"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.7150\/jca.37267","article-title":"Overexpression of DUSP6 enhances chemotherapy-resistance of ovarian epithelial cancer by regulating the ERK signaling pathway","volume":"11","author":"Gao","year":"2020","journal-title":"J Cancer"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2410","article-title":"m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK\/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation","volume":"73","author":"Ma","year":"2021","journal-title":"IUBMB Life"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02209-w","article-title":"Induction of m(6)A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance","volume":"41","author":"Wang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1383232","article-title":"N6-methyladenosine-modified circ_0000337 sustains bortezomib resistance in multiple myeloma by regulating DNA repair","volume":"12","author":"Jiang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12967-022-03456-x","article-title":"Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3\/MYC axis","volume":"20","author":"Wang","year":"2022","journal-title":"J Transl Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.13165","article-title":"METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukaemia","volume":"11","author":"Pan","year":"2021","journal-title":"FEBS Open Bio"},{"key":"B105","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41419-023-06325-7","article-title":"Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy","volume":"14","author":"Liao","year":"2023","journal-title":"Cell Death Dis"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01696-w","article-title":"METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4","volume":"36","author":"Li","year":"2022","journal-title":"Leukemia"},{"key":"B107","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41420-023-01505-y","article-title":"The role of m(6)A demethylase FTO in chemotherapy resistance mediating acute myeloid leukemia relapse","volume":"9","author":"Zhang","year":"2023","journal-title":"Cell Death Discovery"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0097-4","article-title":"A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors","volume":"28","author":"Yan","year":"2018","journal-title":"Cell Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40164-024-00480-z","article-title":"A novel AML1-ETO\/FTO positive feedback loop promotes leukemogenesis and ara-c resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia","volume":"13","author":"Zhou","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00432-020-03373-w","article-title":"High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m(6)A methylation of MYC mRNA","volume":"147","author":"Naren","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0656-9","article-title":"RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1","volume":"34","author":"Elcheva","year":"2020","journal-title":"Leukemia"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23330","article-title":"ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B","volume":"60","author":"Gong","year":"2021","journal-title":"Mol Carcinog"},{"key":"B113","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13046-021-02054-x","article-title":"Synthetic lethality and synergetic effect: the effective strategies for therapy of IDH-mutated cancers","volume":"40","author":"Yao","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4806.20.07024-X","article-title":"Enasidenib and ivosidenib in AML","volume":"111","author":"Martelli","year":"2020","journal-title":"Minerva Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","article-title":"R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m(6)A\/PFKP\/LDHB axis","volume":"81","author":"Qing","year":"2021","journal-title":"Mol Cell"},{"key":"B116","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00848","article-title":"Structure-activity relationships and antileukemia effects of the tricyclic benzoic acid FTO inhibitors","volume":"65","author":"Liu","year":"2022","journal-title":"J Med Chem"},{"key":"B118","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO suppresses cancer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.05.027","article-title":"It's not what you say but how you say it: Targeting RNA methylation in AML","volume":"78","author":"Olsen","year":"2020","journal-title":"Mol Cell"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202106558","article-title":"Glutathione-bioimprinted nanoparticles targeting of N6-methyladenosine FTO demethylase as a strategy against leukemic stem cells","volume":"18","author":"Cao","year":"2022","journal-title":"Small"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.7150\/thno.55574","article-title":"Saikosaponin d exhibits anti-leukemic activity by targeting FTO\/m(6)A signaling","volume":"11","author":"Sun","year":"2021","journal-title":"Theranostics"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0007","article-title":"Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances antitumor immunity","volume":"13","author":"Guirguis","year":"2023","journal-title":"Cancer Discovery"},{"key":"B123","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41568-023-00621-2","article-title":"METTL3 inhibition enhances anti-tumour immunity","volume":"23","author":"Brewer","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01651-9","article-title":"Inhibition of the m(6)A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia","volume":"36","author":"Feng","year":"2022","journal-title":"Leukemia"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01107","article-title":"Identification of potent and selective inhibitors of fat mass obesity-associated protein using a fragment-merging approach","volume":"64","author":"Prakash","year":"2021","journal-title":"J Med Chem"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2020.05.003","article-title":"m(6)A modification prevents formation of endogenous double-stranded RNAs and deleterious innate immune responses during hematopoietic development","volume":"52","author":"Gao","year":"2020","journal-title":"Immunity"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1374390\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T04:55:38Z","timestamp":1716872138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1374390\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":127,"alternative-id":["10.3389\/fimmu.2024.1374390"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1374390","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"article-number":"1374390"}}